BetaGlue Therapeutics SpA
1 clinical trials · Sponsor
◉ Watch BetaGlue Therapeutics SpA
| Record | Firm | Date |
|---|---|---|
| Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC (NCT07155850) | BetaGlue Therapeutics SpA | 2026-02-03 |
Track BetaGlue Therapeutics SpA automatically
Every clearance here is in the API, with alerts when new ones post.